Solid Biosciences Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin | — | — | — |
| Operating Expenses | |||
| Research & Development | $58.0M | $39.9M | $20.1M |
| SG&A Expense | $17.7M | $15.0M | $5.5M |
| Operating Income | $-75.7M | $-54.9M | $-25.6M |
| Operating Margin | — | — | — |
| Interest Expense | — | — | — |
| Pretax Income | — | — | — |
| Income Tax Expense | $0 | — | — |
| Net Income | $-74.8M | $-52.1M | $-21.5M |
| Net Margin | — | — | — |
| EPS (Basic) | $-0.14 | $-0.18 | $-0.63 |
| EPS (Diluted) | $-0.14 | $-0.18 | $-0.63 |
| Shares Outstanding (Basic) | 566.9M | 0 | — |
| Shares Outstanding (Diluted) | 566.9M | 0 | — |
| Dividends Per Share | — | — | — |